Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis
Tofacitinib (TFB) appears to be effective in the treatment of ulcerative colitis (UC); however, available real-world studies are limited by cohort size. TFB could be an option in the treatment of acute severe ulcerative colitis (ASUC). We aimed to investigate efficacy and safety of TFB in moderate-t...
Elmentve itt :
Szerzők: |
Resál Tamás Bacsur Péter Keresztes Csilla Bálint Anita Bor Renáta Fábián Anna Farkas Bernadett Sarlós Patrícia Lakatos Péter László Nyári Tibor András Szepes Zoltán Farkas Klaudia Molnár Tamás et al |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2024
|
Sorozat: | INFLAMMATORY BOWEL DISEASES
30 No. 5 |
Tárgyszavak: | |
doi: | 10.1093/ibd/izad135 |
mtmt: | 34089134 |
Online Access: | http://publicatio.bibl.u-szeged.hu/28131 |
Hasonló tételek
-
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics
Szerző: Dragoni Gabriele, et al.
Megjelent: (2024) -
Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease A Retrospective, Multicentre Study /
Szerző: Farkas Bernadett, et al.
Megjelent: (2024) -
Early versus Late Use of Vedolizumab in Ulcerative Colitis
Szerző: Vermeire Séverine, et al.
Megjelent: (2024) -
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis a promising scoring system /
Szerző: Bacsur Péter, et al.
Megjelent: (2024) -
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Szerző: Garcia Maria Jose, et al.
Megjelent: (2024)